As of December 31, 2025, M1 Kliniken AG carries a market capitalization of 339.51M, placing it among publicly traded companies globally. Its enterprise value stands at 329.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 339.51M |
| Enterprise Value | 329.88M |
As of December 31, 2025, M1 Kliniken AG has 18.78M shares outstanding.
| Shares Outstanding | 18.78M |
These figures are as of December 31, 2025.
| PB Ratio | 2.83 |
| P/TBV Ratio | 11.41 |
As of December 31, 2025, M1 Kliniken AG maintains a current ratio of 2.82, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.82 |
| Quick Ratio | 1.48 |
| Debt / Equity | 4.76 |
As of the close on October 22, 2026, M1 Kliniken AG's stock has gained approximately 30.31% over the past 52 weeks. The 50-day moving average sits at 19.55, while the 200-day moving average is 17.68.
| 52-Week Price Change | 30.31% |
| 50-Day Moving Average | 19.55 |
| 200-Day Moving Average | 17.68 |
As of December 31, 2025, M1 Kliniken AG holds 46.87M in cash and equivalents against 7.15M in total debt, resulting in a net debt position of -37.76M. Total book value stands at 119.93M, with working capital of 57.65M providing operational flexibility.
| Cash & Cash Equivalents | 46.87M |
| Total Debt | 7.15M |
| Net Debt | -37.76M |
| Equity (Book Value) | 119.93M |
| Book Value Per Share | 6.39 |
| Working Capital | 57.65M |
Already premium?